InvestorsHub Logo
Followers 17
Posts 2115
Boards Moderated 0
Alias Born 06/18/2007

Re: A deleted message

Thursday, 10/16/2014 9:14:46 AM

Thursday, October 16, 2014 9:14:46 AM

Post# of 27409
Spam?-Tell that to Dr Chan.
Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents stated, "We are very pleased with our preliminary operating performance for Q3 2014. The increase in sales was across a broad base of both direct customers and distributors. Importantly, we continue to hear positive treatment successes in many different applications, led by sepsis and cardiac surgery, from many different sources, which we will share in greater detail in the future. We continue to believe that our therapy may have applications beyond current uses, including the treatment of Ebola infection, particularly in the terminal phase that is dominated by cytokine storm."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News